Synonyms |
|
|
Clinical
Indications |
|
Calcitonin
is produced by the parafollicular or C-cells of the thyroid
gland. Medullary thyroid carcinoma (MTC) is a tumour of the
calcitonin-producing C-cells which occurs in a sporadic and in
an inherited form. As some MTCs are hereditary it is important
to screen all family members for excess calcitonin when a case
is diagnosed.
Calcitonin is also used in confirmed MTC to monitor treatment,
assess prognosis and detect recurrance
|
Availability |
|
Analysed
by referral
laboratory if specific criteria met.
|
Specific
Criteria |
|
Screening,
diagnosis or monitoring of MTC. In cases of familial origin,
calcitonin can be used as a screening test.
|
Patient
Preparation |
|
Patient
does not need to be fasting.
|
Turnaround
Time |
|
3 weeks
|
Specimen |
|
Serum
|
Volume |
|
2 ml
|
Container |
|
Yellow
Top (SST) tube
|
Collection |
|
Samples should be
transported to laboratory immediately.
|
Lab.
Handling |
|
Separate
2 aliquots within 30 minutes of collection into PLASTIC tubes and freeze at minus 20C. Send sample to
referral laboratory frozen.
|
Causes
for Rejection |
|
Not meeting specific
criteria for analysis. Delay in sample reaching laboratory.
Visible haemolysis invalidates the results.
|
Reference
Range |
|
Less than
0.08 ug/L
|
Interpretation |
|
In
early disease basal levels of calcitonin may be normal.
Increased diagnostic sensitivity may be obtained using
pentagastrin stimulation.
Calcitonin may be raised in other malignancies (breast, lung,
pancreas), phaeochromocytoma, renal failure,
hyperparathyroidism and Paget's disease.
|